HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Anesthetic management of a child with Angelman's syndrome].

Abstract
Angelman syndrome is a hereditary disease described by Angelman. The clinical features of Angelman syndrome are characterized by mental retardation, puppet-like ataxia, easily excitable personality, seizures, paroxysmal laughter, strabismus and macroglossia. A 4-year-old girl with Angelman syndrome underwent strabismus repair under general anesthesia. Anesthesia was slowly induced with sevoflurane in oxygen and maintained with air, oxygen, propofol and remifentanil. Tracheal intubation was performed after administration of rocuronium. During and after anesthesia, no adverse events regarding circulatory and respiratory systems occurred. However, this case demonstrates that it is necessary to pay attention to airway troubles including the difficulty of tracheal intubation, management of body temperature and chronotropic action or respiratory depression by anesthetic agents.
AuthorsNaohiro Ohshita, Yoshinobu Tomiyama, Akio Iseki, Hiroaki Kawano, Nami Kakuta, Yasuo M Tsutsumi, Shuzo P Oshita
JournalMasui. The Japanese journal of anesthesiology (Masui) Vol. 59 Issue 4 Pg. 484-6 (Apr 2010) ISSN: 0021-4892 [Print] Japan
PMID20420140 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Methyl Ethers
  • Piperidines
  • Sevoflurane
  • Remifentanil
  • Propofol
Topics
  • Anesthesia, General
  • Angelman Syndrome (surgery)
  • Child, Preschool
  • Female
  • Humans
  • Intraoperative Care
  • Intubation, Intratracheal
  • Methyl Ethers
  • Monitoring, Intraoperative
  • Piperidines
  • Propofol
  • Remifentanil
  • Sevoflurane
  • Strabismus (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: